Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Dual H1/NK1 antagonists from Hoechst Marion Roussel

July 15, 1997

Sanwa Kagaku discloses novel selectin inhibitors for inflammatory disorders

July 10, 1997

Kotobuki describes new compound with expectorant and antiinflammatory effects

July 8, 1997

Novartis discovers compounds with anti-PDE IV and other actions

July 8, 1997

Update on Alliance/Hoechst Marion Roussel agreement for LiquiVent

July 7, 1997

Orally active H3 receptor agonist prodrug with antiinflammatory/antinicoceptive properties

July 3, 1997

TAK-225 stimulates airways mucociliary transport

July 3, 1997

Sepracor submits first NDA for levalbuterol

July 2, 1997

Schering-Plough and Chiroscience to collaborate on asthma and inflammatory disease treatments

July 1, 1997

Ube/Tanabe evaluating orally active antiallergic/antiasthmatic agent

June 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...